US Patent Issued to AGV Discovery, Institut National de la Sante et de la Recherche Medicale (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Universite De Montpellier on Sept. 23 for "Azaindole derivatives and their use as ERK kinase inhibitors" (French Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,231, issued on Sept. 23, was assigned to AGV Discovery (Montpellier, France), Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and Universite De Montpellier (Montpellier, France).

"Azaindole derivatives and their use as ERK kinase inhibitors" was invented by Cedric Bories (Jacou, France), Loic Mathieu (Lyons, France), Jean-Francois Guichou (Torreilles, France), Muriel Gelin (Clapiers, France) and Aurelien Biechy (Boulogne-Billancourt, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns a compound of formula (I):or one of its pharm...